• Find a fund

    Fund type

    Asset class

    Product range

  • Insights and researchEvents and webinarsEvents and webinarsEvents and webinars

    Markets and economic outlook

  • Our servicesDiscover Vanguard 365""Client Connect: The Vanguard Advice Survey""
  • About VanguardAbout VanguardOur team""Fraud prevention""

    Corporate reports

    • Selected Screened FTSE Developed Europe II Common Contractual Fund - Institutional EUR Acc (VAECIBE)

    Related Documents
    NAV Price ()
    —
    Number of stocks
    —
    —
    Risk Indicator
    —

    About this fund

    Fund objectives

    • The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and aims to provide long-term growth of capital by seeking to achieve the performance of the FTSE Developed Europe Index (the “Index”).
    • The Index is a market-capitalisation-weighted index of common stock of large and mid-sized companies in developed countries in Europe.
    • Through the screening out of stocks of companies from its portfolio based on the potentially detrimental impact of the issuer's conduct or products on society, the Fund promotes certain social characteristics relating to social norms and standards.
    • The Fund attempts to: 1. Match the risk factor exposures of the Index by investing in a representative sample of the securities that make up the Index, excluding Index constituents that are issued by companies which (as determined by the Index provider) are involved in certain business activities related to (1) chemical and biological weapons, (2) cluster munitions, (3) anti-personnel landmines, (4) nuclear weapons, and/or (5) manufacture and distribution of tobacco products. The screening process also seeks to exclude Index constituents that are issued by companies based on certain controversial conduct, which is achieved by excluding companies that have been deemed ‘Non-Compliant’ in relation to the United Nations Global Compact Principles regarding labour, human rights, environmental, and anti-corruption standards through third party data which is utilised by the Index provider. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.
    • Company product and conduct involvement is monitored on a yearly basis by the Index provider and as new data is made available to the Index provider.
    • For the full investment strategy please review the prospectus.

    Fund facts

    Share class inception
    17 Nov 2017
    Minimum initial investment
    €30,000,000.00
    Investment structure
    Irish UCITS
    Share Class Assets'
    Total Assets
    Strategy
    Index
    Asset Class
    Equity
    Domicile
    Ireland
    Dividend schedule
    —
    Legal entity
    Vanguard Investments II Common Contractual Fund
    Benchmark
    FTSE Developed Europe Index
    Register countries
    Netherlands

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Sustainability-related disclosures

    • This product promotes, among other characteristics, environmental or social characteristics, or a combination of those characteristics as specified under Article 8 of the EU SFDR.
    • Refer to the “Sustainability-related disclosures” document at the top of the webpage for the detailed disclosures in accordance with SFDR.

    Performance

    Risk and Volatility

    As at 31 Jan 2026

    Beta
    R²
    Annualized Tracking Error
    1 year
    3 years
    5 years

    Please note Beta and R-squared data will only display for funds with 3 full years of history.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Portfolio data

    Characteristics
    FundamentalsFundBenchmarkAs at
    Number of stocks 488 504 31 Jan 2026
    Median market capital 63.6 B 78.2 B 31 Jan 2026
    17.3 x 17.5 x 31 Jan 2026
    2.4 x 2.4 x 31 Jan 2026
    13.8% 14.0% 31 Jan 2026
    15.1% 14.5% 31 Jan 2026
    Portfolio turnover rate 3.3% — 31 Dec 2025

    Market allocation

    As at 31 Jan 2026

    CountryRegionFundBenchmarkVariance +/-
    United KingdomEurope 22.19% 23.07% -0.88%
    SwitzerlandEurope 14.52% 14.40% 0.12%
    GermanyEurope 14.37% 13.87% 0.50%
    FranceEurope 13.86% 15.11% -1.25%
    NetherlandsEurope 7.80% 7.83% -0.03%
    SpainEurope 6.11% 5.86% 0.25%
    ItalyEurope 5.34% 5.22% 0.12%
    SwedenEurope 5.22% 5.35% -0.13%
    DenmarkEurope 2.82% 2.89% -0.07%
    BelgiumEurope 1.80% 1.70% 0.10%
    FinlandEurope 1.73% 1.70% 0.03%
    NorwayEurope 1.09% 0.90% 0.19%
    OtherOther 0.98% 0.00% 0.98%
    PolandEurope 0.71% 0.72% -0.01%
    AustriaEurope 0.59% 0.54% 0.05%

    Holdings details

    As at 31 Jan 2026

    Holding name% of market valueSectorRegionMarket valueShares
    ASML Holding NV 3.83339% Technology NL €10,653,518.40 8,764
    Roche Holding AG 2.02449% Health Care CH €5,626,344.43 14,697
    Novartis AG 1.96187% Health Care CH €5,452,298.04 43,577
    AstraZeneca PLC 1.92203% Health Care GB €5,341,583.61 34,050
    Nestle SA 1.65807% Consumer Staples CH €4,608,001.20 57,488
    Shell PLC 1.64192% Energy GB €4,563,107.71 141,586
    Siemens AG 1.52620% Industrials DE €4,241,508.70 16,549
    SAP SE 1.45168% Technology DE €4,034,426.24 23,654
    Banco Santander SA 1.34671% Financials ES €3,742,697.42 347,189
    Novo Nordisk A/S 1.23857% Health Care DK €3,442,142.66 69,557

    Total allocation percentages shown in the holdings details or the spreadsheet may not equal 100%, due to rounding or omission of cash and/or derivative instruments.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Weighted equity exposures exclude any temporary cash investments and equity index derivatives.

    Prices and distribution

    Prices

    NAV Price (EUR)
    €199.46
    Change
    +€0.210.11%
    At closure 16 Feb 2026
    NAV 52-week high
    €200.41
    At closure 18 Feb 2026
    NAV 52-week low
    €149.43
    At closure 18 Feb 2026
    NAV 52-week difference
    €50.98
    Change
    +25.44%
    At closure 18 Feb 2026
    Historical Prices

    -

    Inception date

    17 Nov 2017

    Date NAV (EUR)
    16 Feb 2026 €199.4600
    13 Feb 2026 €199.2492
    12 Feb 2026 €199.5509
    11 Feb 2026 €200.4129
    10 Feb 2026 €200.1272
    09 Feb 2026 €200.1967
    06 Feb 2026 €198.7965
    05 Feb 2026 €197.0886
    04 Feb 2026 €199.5948
    03 Feb 2026 €199.0570

    Distribution history

    Distribution frequency

    —

    Historical performance 31 Jan 2026

    2.80%

    All dividends are reinvested for the "Accumulation" shares.

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    Purchase information

    Currency

    Base currency: EUR

    Fund codes

    • Bloomberg: VAECIBE
    • Citi: O8G5
    • ISIN: IE00BD2N6761
    • MEX ID: VISMA
    • SEDOL: BD2N676

    The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

    SEDOL and SEDOL Masterfile® are registered trademarks of the London Stock Exchange Group PLC. SEDOL data was extracted from the London Stock Exchange SEDOL Masterfile®.